Drug Type Small molecule drug |
Synonyms ClozaBen |
Mechanism 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), DAAO inhibitors(D-amino-acid oxidase inhibitors), DRDs antagonists(Dopamine receptors antagonists) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2/3 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H19ClN4 |
InChIKeyQZUDBNBUXVUHMW-UHFFFAOYSA-N |
CAS Registry5786-21-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia, Treatment-Resistant | Phase 3 | - | - |